NCT01848730View on ClinicalTrials.gov

Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

May 31, 2014

Conditions
Post-herpetic Neuralgia
Interventions
DRUG

CNV2197944

DRUG

Placebo

Trial Locations (1)

Unknown

Christiaan Barnard Memorial Hospital, Cape Town

Sponsors
All Listed Sponsors
lead

Convergence Pharmaceuticals

INDUSTRY